My primary clinical and research interest involves clinical investigation aimed at improving care and outcome of Hodgkin and Non-Hodgkin lymphoma patients. I am also interested in the applications of tumor immunology and immunotherapy to hematologic malignancies focusing on lymphoma. My overall goal is to be a clinician scientist, initiating clinical trials that utilize novel agents and advancing correlative science including biomarker development. In addition, I want to understand and apply principles of risk stratification for treatment selection aimed at optimizing efficacy and minimizing toxicity.
The following timeline graph is generated from all co-authored publications.Featured publications are shown below:
No featured affiliations
View all affiliations
No address provided
MeSH terms are retrieved from PubMed records. Learn more.
Key: MeSH Term KeywordAdolescent Adult Antineoplastic Agents Carcinogens, Environmental Child Child, Preschool Female Gastrointestinal Stromal Tumors Genetic Predisposition to Disease Herpesvirus 4, Human Hodgkin Disease immunology Infant Killer Cells, Natural Lung Neoplasms Lymphoma lymphoma Magnetic Resonance Imaging Male Natural Killer T-Cells Non-Hodgkin Plasma Cell Disorders Protein-Tyrosine Kinases Protein Kinase Inhibitors Radon Receptor Protein-Tyrosine Kinases Response Evaluation Criteria in Solid Tumors Retrospective Studies Risk Factors Sarcoma Signal Transduction Smoking Treatment Outcome Tumor Burden United States